How tired are you right now? If you're like many Americans, your answer probably leans more toward the sleep-deprived side.
Fifty to 70 million of us suffer from sleep problems, according to the National Sleep Foundation. And it's not just falling asleep that vexes us. The Center for Disease Control and Prevention found that one-third of the U.S population -- 100 million people -- aren’t staying asleep during the night.
“As a nation, we are not getting enough sleep,” says Dr. Wayne Giles, M.D., the standing director of the CDC’s Division of Population Health. To compound its importance, lack of sleep negatively affects overall health. A recent study found that individuals with insomnia are five times more likely to suffer from anxiety or depression and have double the risk of congestive heart failure.
Cannabis in Light of the Opioid Crisis
It’s been hotly debated for years: Does cannabis have a legitimate medical use? It’s a Schedule I drug in the United States, meaning the federal government’s official view was—and still is—that marijuana has no legitimate medical purpose. Individual states, however, have recognized the research on marijuana’s clinical benefits for a variety of conditions. Now the first cannabis-derived drug—Epidolex, an oral cannabidiol (CBD) solution used to ease seizures in two rare forms of epilepsy—has been approved by the FDA, and the specific formulation rescheduled to Schedule V (meaning it has accepted medical use and low potential for abuse). This doesn’t affect the scheduling of other CBD products but may open the door for other cannabis-derived drugs in the future.